SARS-CoV-2 Nucleocapsid Produits
(SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N))
Catégories
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories SARS-CoV-2 Nucleocapsid en vedette
SARS-CoV-2 Nucleocapsid Anticorps
High quality antibodies with extensive validation data.
SARS-CoV-2 Nucleocapsid Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
SARS-CoV-2 Nucleocapsid recommandé Anticorps
- (6)
- (3)
- (1)
- (2)
- (3)
- (2)
SARS-CoV-2 Nucleocapsid recommandé Kits ELISA
SARS-CoV-2 Nucleocapsid recommandé Protéines
- (5)
- (2)
- (1)
- (2)
- (1)
Dernières publications sur nos produits SARS-CoV-2 Nucleocapsid
: "Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection." dans: PloS one, Vol. 18, Issue 2, pp. e0281281, (2023) (PubMed).: "Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell®. ..." dans: Vaccines, Vol. 11, Issue 4, (2023) (PubMed).
: "Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2. ..." dans: Nature communications, Vol. 14, Issue 1, pp. 3583, (2023) (PubMed).
: "Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Issue 30, pp. e2221809120, (2023) (PubMed).
: "Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern." dans: Journal of dairy science, (2022) (PubMed).
: "Identification of cell type specific ACE2 modifiers by CRISPR screening." dans: PLoS pathogens, Vol. 18, Issue 3, pp. e1010377, (2022) (PubMed).
: "The Potential of Eukaryotic Cell-Free Systems as a Rapid Response to Novel Zoonotic Pathogens: Analysis of SARS-CoV-2 Viral Proteins." dans: Frontiers in bioengineering and biotechnology, Vol. 10, pp. 896751, (2022) (PubMed).
: "Paper-Based Test for Rapid On-Site Screening of SARS-CoV-2 in Clinical Samples." dans: Biosensors, Vol. 11, Issue 12, (2022) (PubMed).
: "ARF6 is an important host factor for SARS-CoV-2 infection in vitro." dans: bioRxiv : the preprint server for biology, (2022) (PubMed).
: "Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial." dans: Virus research, Vol. 316, pp. 198791, (2022) (PubMed).
Synonymes et noms alternatifs relatifs à SARS-CoV-2 Nucleocapsid
nucleocapsid phosphoprotein (N)Avez-vous cherché autre chose?
- SARS-CoV-2 NSP9
- SARS-CoV-2 NSP8
- SARS-CoV-2 NSP7
- SARS-CoV-2 NSP6
- SARS-CoV-2 NSP5 (3CL-Pro)
- SARS-CoV-2 NSP4
- SARS-CoV-2 NSP3
- SARS-CoV-2 NSP2
- SARS-CoV-2 NSP16
- SARS-CoV-2 NSP15
- SARS-CoV-2 NSP14
- SARS-CoV-2 NSP13
- SARS-CoV-2 NSP12 (RdRP)
- SARS-CoV-2 NSP10
- SARS-CoV-2 NSP1
- SARS-CoV-2 Membrane Protein
- SARS-CoV-2 Envelope
- SARS-CoV-2 (CB6 Biosimilar)
- SARS-CoV-2
- SARS-CoV Spike